Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia

NCT06311227 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT06311227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 16, 2024
Completion date
May 20, 2027
Enrollment
20 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent hairy cell leukemia, recurrent hairy cell leukemia variant